Clinical Trial Update: Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on tipifarnib for myelofibrosis and related myeloproliferative disorders, with the study having completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Essential Thrombocythemia, Polycythemia Vera | Phase 2 | Status: COMPLETED